The comparative analysis of in vivo and in vitro transcriptome data based on systems biology

[1]  E. General.  People for the Ethical Treatment of Animals , 2012 .

[2]  Edward J. Perkins,et al.  In vitro gene regulatory networks predict in vivo function of liver , 2010, BMC Systems Biology.

[3]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[4]  P. Ganey,et al.  Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury , 2009, Journal of Pharmacology and Experimental Therapeutics.

[5]  P. Borm,et al.  Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region , 2008, Inhalation toxicology.

[6]  Van V. Brantner,et al.  Estimating the cost of new drug development: is it really 802 million dollars? , 2006, Health affairs.

[7]  M. Sulaiman,et al.  Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study , 2004, Human & experimental toxicology.

[8]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[9]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[10]  R. Rodriguez,et al.  Hepatotoxicity of ketoconazole in Sprague-Dawley rats: glutathione depletion, flavin-containing monooxygenases-mediated bioactivation and hepatic covalent binding , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  M. Wick,et al.  Peroxisome Proliferator-Activated Receptor-γ Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth , 2002 .

[12]  C. Mayhew,et al.  In Vivo and In Vitro Comparison of the Short‐Term Hematopoietic Toxicity Between Hydroxyurea and Trimidox or Didox, Novel Ribonucleotide Reductase Inhibitors with Potential Anti‐HIV‐1 Activity , 1999, Stem cells.

[13]  James H. Lewis,et al.  NSAID-INDUCED HEPATOTOXICITY , 1998 .

[14]  J. Lehmann,et al.  Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.

[15]  M. Gómez-Lechón,et al.  Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity. , 1999, The Journal of pharmacology and experimental therapeutics.

[16]  U. Boelsterli,et al.  Reactive oxygen species and non-peroxidative mechanisms of cocaine-induced cytotoxicity in rat hepatocyte cultures. , 1991, Toxicology.